Therakos, Inc., a Mallinckrodt Company

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Regulatory

19821 event

FDAJan 1

8-Mop — 8-MOP

Application NDA009048 (NDA)

19861 event

FDAOct 30

8-Mop — OXSORALEN-ULTRA

Application NDA019600 (NDA)

19991 event

FDAFeb 25

8-Mop — UVADEX

Application NDA020969 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)